Rising Prevalence Of Cardiovascular Diseases Driving The Leqvio Market Growth: A Key Driver Powering Leqvio Market Growth In 2025

The Leqvio Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Current Leqvio Market Size and Its Estimated Growth Rate?
In recent times, the market size for leqvio has increased by XX (HCAGR). It's predicted to expand from $XX million in 2024 to $XX million in 2025, indicating a compound annual growth rate (CAGR) of XX%. Factors contributing to the growth during the historic period include greater funding for RNA-based drug development, elevated expenditure on cholesterol management drugs, enhanced investment into research and development and drug discovery, improved healthcare consciousness, and a surging demand for specialized medications.

It is projected that the leqvio market will experience an increase of XX (FCAGR) in the coming years, eventually reaching an estimated value of $XX million in 2029, with a compound annual growth rate of XX%. This anticipated growth during the forecast period can be related to a global rise in heart disease, increased awareness of the effectiveness of PCSK9 inhibitors, a rise in high cholesterol cases, an expanding elderly population, and the proliferation of biologic drugs. Future trends are expected to include a heightened drive for advanced treatments for high cholesterol, the broadening of indications through ongoing studies, ongoing approval by regulatory bodies like the FDA, advancements in biopharmaceutical studies, and improved drug development processes.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20143

How Are Emerging Segments Shaping the Leqvio Market Landscape?
The leqvio market covered in this report is segmented -

1) By Formulation: Injectable Formulation (Subcutaneous), Pre-Filled Syringes Or Auto-Injectors
2) By Indication: Treatment Of Hyperlipidemia, Management Of Atherosclerotic Cardiovascular Disease (ASCVD), Treatment Of Familial Hypercholesterolemia
3) By Patient Demographics: Adult Patients, Geriatric Patients, Patients with Comorbid Conditions
4) By Distribution Channel: Direct Sales, Wholesalers and Distributors, Retail Pharmacies, Online Pharmacies
5) By End-User: Hospitals, Cardiovascular Clinics, Specialty Pharmacies, Home Healthcare Providers

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20143&type=smp

Which Growth Factors Are Influencing Leqvio Market Expansion?
The growth of the leqvio market is anticipated to be propelled by the escalating occurrence of cardiovascular diseases. These diseases, which affect the heart and blood vessels, often lead to complications such as heart attacks, strokes, and hypertension. A variety of factors like unhealthy eating habits, sedentary lifestyle, overconsumption of alcohol, diabetes, and increasing age contribute to the onset of these diseases. Leqvio functions by inhibiting the PCSK9 protein, boosting the liver's capacity to remove LDL cholesterol from the bloodstream. This aids in decreasing LDL levels, lessening the likelihood of cardiovascular catastrophes like heart attacks and strokes. For example, data from the British Heart Foundation, a cardiovascular research charity in the UK, revealed in September 2024 that about 7.6 million individuals are living with heart and circulatory diseases in the UK. This population consists of approximately 4 million men and 3.6 million women. These ailments account for nearly 27% of all UK deaths, leading to over 170,000 fatalities each year, or close to 480 deaths every day, which is equivalent to one death every three minutes. Consequently, the rising incidence of cardiovascular diseases is fuelling the Leqvio market's expansion.

Who Are the Dominant Players Across Different Leqvio Market Segments?
Major companies operating in the leqvio market include Novartis AG

What Are the Major Trends Shaping the Adbry/Adtralza Market?
The prominent trend in the leqvio market revolves around the creation of sophisticated injectable prescribed drugs aimed at providing long-duration treatments that enhance patient compliance and results. The term "injectable prescription medication" denotes treatments administered through injection to control high cholesterol levels and minimize risks related to heart disease. These drugs are typically given at regular intervals to maintain their therapeutic effects. For instance, in July 2023, Novartis, a pharmaceutical company based in Switzerland, obtained approval from the US Food and Drug Administration (FDA) for a label update for Leqvio (inclisiran), granting approval for its usage for patients at an earlier stage with high LDL-C and a heightened risk of cardiac disease, along with diet and statin therapy. The twice-yearly administration, following two loading doses, results in up to a 52% decrease in LDL-C and is proven effective for those patients who can't reach their LDL-C targets despite undergoing statin therapy. The VictORION clinical trial program reinforces the label update due to its strong safety and efficacy data.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/leqvio-global-market-report

Which Geographic Regions Are Expected to Dominate the Leqvio Market in the Coming Years?
North America was the largest region in the leqvio market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the leqvio market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Leqvio Market?
2. What is the CAGR expected in the Leqvio Market?
3. What Are the Key Innovations Transforming the Leqvio Industry?
4. Which Region Is Leading the Leqvio Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.